A Summary of available information on patients suffering from blood disorders and blood cancers are summarised here.
Blood Cancers
The figures mentioned here are from the estimation by the Global Cancer Observatory (Globocan) for the year 2020. The estimations were published in 2021. Statistics of various countries can be found here:
https://gco.iarc.fr/today/
Statistics for Bangladesh can be found here: https://gco.iarc.fr/
Estimated New cases of blood cancer in Bangladesh in 2020:
Non Hodgkin Lymphoma: 3327
Leukaemia: 2821
Multiple Myeloma: 805
Hodgkin Lymphoma: 548
Total: 7501
Estimated 5-year prevalence of blood cancer in Bangladesh in 2020 (per 100,000 people, in parentheses):
Non Hodgkin Lymphoma: 7692 (4.67)
Leukaemia: 6912 (4.20)
Multiple Myeloma: 1590 (0.97)
Hodgkin Lymphoma: 1473 (0.89)
Total: 17667 (10.73)
Estimated New deaths from blood cancer in Bangladesh in 2020:
Non Hodgkin Lymphoma: 1998
Leukaemia: 2132
Multiple Myeloma: 728
Hodgkin Lymphoma: 213
Total: 5071
Thalassemia and Hemoglobinopathies
Regional Desk Review published by South East Asia Regional Office of World Health Organization in 2021 estimates that combined prevalence of beta thalassemia trait and hemoglobin E trait carrier frequency in Bangladesh is 10.92%. The estimates suggested that more than 9000 children are born with thalassemia in the country each year and between sixty and seventy thousand patients currently live with hemoglobin E or beta thalassemia in Bangladesh.
Hemophilia and Bleeding Disorders
Almost 2500 patients with hemophilia and other bleeding disorders have been reported to World Bleeding Disorder Registry by World Federation of Hemophilia according to their report on annual global Survey of 2021. It is estimated that more than 14,000 males are currently living with haemophilia in Bangladesh and theoretically, over 400 children are born with haemophilia every year in Bangladesh (https://doi.org/10.1111/hae.14445).